Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral contraceptives and birth defects.

K J Rothman, C Louik

    The New England Journal of Medicine
    |September 7, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Oral contraceptives (OCs) do not pose a major teratogenic risk. While minor malformations were slightly higher in infants exposed shortly before conception, major birth defects showed no significant difference, suggesting OCs are generally safe.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Preconception sleep duration, non-daytime work schedules, and incidence of spontaneous abortion: a prospective cohort study.

    Human reproduction (Oxford, England)·2023
    Same author

    Self-reported periodontitis and fecundability in a population of pregnancy planners.

    Human reproduction (Oxford, England)·2021
    Same author

    Male cellular telephone exposure, fecundability, and semen quality: results from two preconception cohort studies.

    Human reproduction (Oxford, England)·2021
    Same author

    Male alcohol consumption and fecundability.

    Human reproduction (Oxford, England)·2020
    Same author

    Lubricant use during intercourse and time to pregnancy: a prospective cohort study.

    BJOG : an international journal of obstetrics and gynaecology·2018
    Same author

    Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States.

    The British journal of dermatology·2015

    Area of Science:

    • Reproductive Health
    • Teratology
    • Perinatal Epidemiology

    Background:

    • Concerns exist regarding the potential teratogenic effects of oral contraceptives (OCs).
    • Understanding the risks associated with OC use shortly before conception is crucial for public health.
    • Previous studies have yielded conflicting results on the safety of OCs during early pregnancy.

    Purpose of the Study:

    • To investigate the association between maternal oral contraceptive use shortly before conception and infant malformations.
    • To determine if oral contraceptive exposure poses a significant teratogenic hazard.
    • To compare malformation rates in infants exposed to OCs versus those not exposed.

    Main Methods:

    • Retrospective review of birth certificates and hospital records for 7723 infants.

    Related Experiment Videos

  • Categorization of infants based on maternal oral contraceptive use patterns prior to conception.
  • Statistical analysis to compare malformation frequencies and calculate prevalence ratios with confidence intervals.
  • Main Results:

    • Overall malformation frequency was 4.3% in infants whose mothers used OCs shortly before conception, versus 3.3% in controls (prevalence ratio 1.0-1.7).
    • No significant difference was observed in the prevalence of major malformations between the groups.
    • A slight excess of minor malformations, including undescended testis, was noted in the exposed group but could be attributed to sampling variability.

    Conclusions:

    • Oral contraceptives do not appear to present a major teratogenic hazard.
    • The observed slight increase in minor malformations warrants further investigation but does not indicate a significant risk.
    • Current data suggest that oral contraceptive use shortly before conception is generally safe regarding major congenital anomalies.